attruby news - Search News

FDA, ttr and Attruby

FDA approves BridgeBio’s Attruby for ATTR-CM treatment

The US Food and Drug Administration (FDA) has approved BridgeBio Pharma’s Attruby (acoramidis), an oral transthyretin (TTR) stabiliser, to treat adults with transthyretin amyloid cardiomyopathy (ATTR-CM).

GEN · 1d

Bridgebio’s Attruby, to Treat Heart Condition ATTR-CM, Receives FDA Approval

Attruby (acoramidis), a near complete TTR stabilizer, has been approved by FDA to reduce cardiovascular death and hospitalization in ATTR-CM patients.

WebMD · 1d

FDA Approves New Drug for Life-Threatening Heart Condition

The FDA has approved Attruby, a new oral treatment that helps reduce heart-related deaths and hospital visits among adults with transthyretin amyloid cardiomyopathy, or ATTR-CM.

12h

BridgeBio Selects PANTHERx® Rare Specialty Pharmacy for Distribution of Attruby™ (acoramidis)

PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to ...

US FDA approves BridgeBio's drug for rare heart condition (Nov 22)

The U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said ...

Monthly Prescribing Reference1d

Attruby Approved for Cardiomyopathy of Transthyretin-Mediated Amyloidosis

The Food and Drug Administration (FDA) has approved Attruby TM (acoramidis) for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults to ...

Newsable Asianet News on MSN1d

BridgeBio Stock Hits 2-Month Highs After Analysts Cheer FDA Nod For Heart Drug: Retail Excitement Builds

BridgeBio Pharma Inc. ($BBIO) stock surged 28% on Monday morning, hitting highs last seen in mid-September, after the company ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

FDA, ttr and Attruby

Related topics